
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Short Communication |
1 Division of Cancer Epidemiology and Genetics, National Cancer Institute, Department of Health and Human Services, NIH, Bethesda, Maryland; 2 Kaiser Permanente, Portland, Oregon; 3 Information Management Services, Silver Spring, Maryland; and 4 Digene, Gaithersburg, Maryland
Requests for reprints: Attila T. Lorincz, Digene Corporation, 1201 Clopper Road, Gaithersburg, MD 20878. E-mail: attila.lorincz{at}digene.com
We examined whether higher human papillomavirus type 16 (HPV16) viral load predicted risk of cervical intraepithelial neoplasia 3 (CIN3) or cancer (together termed
CIN3) within a cohort of 20,810 women followed for 10 years with cytologic screening. Semiquantitative viral load for HPV16 was measured on baseline cervicovaginal specimens using a type-specific hybridization probe test with signal amplification. An increased risk of
CIN3 associated with higher HPV16 viral load was found only among cytologically negative women in early follow-up, suggesting that these cases were related to the detection of prevalent lesions missed at baseline. Women with higher HPV16 viral load were more likely to undergo ablative treatment during follow-up than those with lower viral load (Ptrend = 0.008), possibly diminishing any additional risk for
CIN3 attributable to higher HPV16 viral loads.
This article has been cited by other articles:
![]() |
J. L. K. Cheung, T. H. Cheung, J. W. T. Tang, and P. K. S. Chan Increase of Integration Events and Infection Loads of Human Papillomavirus Type 52 with Lesion Severity from Low-Grade Cervical Lesion to Invasive Cancer J. Clin. Microbiol., April 1, 2008; 46(4): 1356 - 1362. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. B. Kovacic, P. E. Castle, R. Herrero, M. Schiffman, M. E. Sherman, S. Wacholder, A. C. Rodriguez, M. L. Hutchinson, M. C. Bratti, A. Hildesheim, et al. Relationships of human papillomavirus type, qualitative viral load, and age with cytologic abnormality. Cancer Res., October 15, 2006; 66(20): 10112 - 10119. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Cell Growth & Differentiation |